psoralidin
CAS: 18642-23-4
Ref. 3D-FP73918
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado |
Informação sobre produto
Nome:
psoralidin
Sinónimos:
- 3,9-Dihydroxy-2-(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-6-one
- 3,9-Dihydroxy-2-(3-methyl-2-butenyl)-6H-benzofuro(3,2-c)(1)benzopyran-6-one
- 3,9-Dihydroxy-2-(3-methylbut-2-enyl)-[1]benzofuro[3,2-c]chromen-6-one
- 3,9-dihydroxy-2-(3-methylbut-2-en-1-yl)-6H-[1]benzofuro[3,2-c]chromen-6-one
- 3-Benzofurancarboxylic acid, 2-[2,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl]-6-hydroxy-, δ-lactone
- 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-butenyl)-
- 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-buten-1-yl)-
- Psoralidin
Descrição:
Psoralidin is a pharmacological agent that induces apoptosis in cancer cells. It binds to the response element of the pro-apoptotic gene, PUMA, and causes the activation of several proteins involved in the apoptosis pathway. It has been shown to successfully induce cell death in HL-60 cells and murine hepatoma cells. Psoralidin is also able to inhibit cancer cell proliferation by suppressing the expression of oncogenes such as MMP-2, MMP-9, and COX-2. The mechanism by which psoralidin induces apoptosis is not yet fully understood but may be due to its ability to induce endoplasmic reticulum stress or activate caspases.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
